Is androgenetic alopecia a risk for atherosclerosis?

Journal of the European Academy of Dermatology and Venereology

Volumn 23, Issue 6, 2009, Pages 673-677

  Dogramaci, A C ^a   Balci, D D ^a   Balci, A ^a   Karazincir, S ^a   Savas, N ^a   Topaloglu, C ^a   Yalcin, F ^a  

^a MUSTAFA KEMAL UNIVERSITY   (Turkey)

Author keywords

Androgenic alopecia; Carotid intima media thickness; High sensitive C reactive protein; Subclinical atherosclerosis; Vertex pattern

Indexed keywords

C REACTIVE PROTEIN; PRASTERONE SULFATE; TESTOSTERONE;

ADULT; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; ECHOCARDIOGRAPHY; EXERCISE ELECTROCARDIOGRAPHY; HUMAN; HYPERTENSION; KIDNEY FAILURE; LIPID BLOOD LEVEL; MALE; MALE TYPE ALOPECIA; PRIORITY JOURNAL; TESTOSTERONE BLOOD LEVEL;

ADULT; ALOPECIA; ATHEROSCLEROSIS; C-REACTIVE PROTEIN; CAROTID ARTERIES; CASE-CONTROL STUDIES; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; EXERCISE TEST; HUMANS; MALE; MIDDLE AGED;

EID: 67649684359     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2009.03137.x     Document Type: Article

References (31)

1. Olsen EA, Whiting D, Bergfeld W et al. A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men. J Am Acad Dermatol 2007 57 : 767 774. (Pubitemid 47553065)
2. Singh G. Androgenic alopecia. Indian J Dermatol Venereol Leprol 2002 68 : 40. (Pubitemid 44058012)
3. Lesko SM, Rosenberg L, Shapiro S. A case-control study of baldness in relation to myocardial infarction in men. JAMA 1993 269 : 998 1003. (Pubitemid 23066636)
4. Lotufo PA, Chae CU, Ajani UA et al. Male pattern baldness and coronary heart disease: the physicians' health study. Arch Intern Med 2000 160 : 165 171. (Pubitemid 30054335)
5. Herrera CR, D'Agostino RB, Gerstman BB et al. Baldness and coronary heart disease rates in men from the Framingham Study. Am J Epidemiol 1995 142 : 828 833.
6. Miric D, Fabijanic D, Giunio L et al. Dermatological indicators of coronary risk: a case-control study. Int J Cardiol 1998 67 : 251 255. (Pubitemid 29029991)
7. Gutersohn T, Scheidegger EP. Is baldness bad for the heart? Dermatology 2005 211 : 72 74. (Pubitemid 40911567)
8. Shahar E, Heiss G, Rosamond WD, Szklo M. Baldness and myocardial infarction in men: the atherosclerosis risk in communities study. Am J Epidemiol 2008 167 : 676 683.
9. Rebora A. Baldness and coronary artery disease: the dermatologic point of view of a controversial issue. Arch Dermatol 2001 137 : 943 947. (Pubitemid 32641656)
10. Günes Y, Tuncer M, Yildirim M et al. A novel echocardiographic method for the prediction of coronary artery disease. Med Sci Monit 2008 14 : 42 46.
11. Kuller LH, Shemanski L, Psaty BM et al. Subclinical disease as an independent risk factor for cardiovascular disease. Circulation 1995 92 : 720 726.
12. Persson J, Forgren J, Israelsson B, Berglund G. Ultrasound-determined intima-media thickness and atherosclerosis. Direct and indirect validation. Arterioscler Thromb 1994 14 : 261 264.
13. Hung J, Knuiman MW, Divitini ML et al. Prevalence and risk factor correlates of elevated C-reactive protein in an adult Australian population. Am J Cardiol 2008 101 : 193 198.
14. Ridker PM, Stampfer MJ, Rifai N. Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocycteine, lipoprotein (a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA 2001 285 : 2481 2485. (Pubitemid 32433842)
15. Leu HB, Lin CP, Lin WT et al. Risk stratification and prognostic implication of plasma biomarkers in nondiabetic patients with stable coronary artery disease: the role of high-sensitivity C-reactive protein. Chest 2004 126 : 1032 1039.
16. Sabatine MS, Morrow DA, Jablonski KA et al. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease. Circulation 2007 115 : 1528 1536. (Pubitemid 46648637)
17. Alvarez Garcia B, Ruiz C, Chacon P et al. High-sensitivity C-reactive protein in high-grade carotid stenosis: risk marker for unstable carotid plaque. J Vasc Surg 2003 38 : 1018 1024. (Pubitemid 37409637)
18. Hamilton JB. Patterned loss of hair in man; types and incidence. Ann NY Acad Sci 1951 53 : 708 728.
19. Norwood OT. Male pattern baldness: classification and incidence. South Med J 1975 68 : 1359 1365.
20. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002 106 : 3143 3421.
21. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M Mode echocardiographic measurements. Circulation 1978 58 : 1072 1083.
22. Weiner DA, Ryan TJ, McCabe CH. Prognostic importance of a clinical profile and exercise test in medically treated patients with coronary artery disease. J Am Coll Cardiol 1984 3 : 772 779. (Pubitemid 14166248)
23. Schnohr P, Lange P, Nyboe J et al. Gray hair, baldness, and wrinkles in relation to myocardial infarction: the Copenhagen City Heart Study. Am Heart J 1995 130 : 1003 1010.
24. van der Meer IM, Bots ML, Hofman A et al. Predictive value of noninvasive measures of atherosclerosis for incident myocardial infarction: the Rotterdam Study. Circulation 2004 109 : 1089 1094. (Pubitemid 38332611)
25. Dunajska K, Milewicz A, Szymczak J et al. Evaluation of sex hormone levels and some metabolic factors in men with coronary atherosclerosis. Aging Male 2004 7 : 197 204. (Pubitemid 39315123)
26. Wynne FL, Khalil RA. Testosterone and coronary vascular tone: implications in coronary artery disease. J Endocrinol Invest 2003 26 : 181 186. (Pubitemid 36503069)
27. Fujimoto R, Morimoto I, Morita E et al. Androgen receptors, 5 alpha-reductase activity and androgen-dependent proliferation of vascular smooth muscle cells. J Steroid Biochem Mol Biol 1994 50 : 169 174. (Pubitemid 24265230)
28. Debing E, Peeters E, Duquet W et al. Men with atherosclerotic stenosis of the carotid artery have lower testosterone levels compared with controls. Int Angiol 2008 27 : 135 141.
29. Stanczyk FZ. Diagnosis of hyperandrogenism: biochemical criteria. Best Pract Res Clin Endocrinol Metab 2006 20 : 177 191. (Pubitemid 43842929)
30. Olsen MH, Christensen MK, Hansen TW et al. High-sensitivity C-reactive protein is only weakly related to cardiovascular damage after adjustment for traditional cardiovascular risk factors. J Hypertens 2006 24 : 655 661.
31. Sasmaz S, Senol M, Ozcan A et al. The risk of coronary heart disease in men with androgenetic alopecia. J Eur Acad Dermatol Venereol 1999 12 : 123 125. (Pubitemid 29234445)